250 related articles for article (PubMed ID: 25883195)
1. Achievement of therapeutic targets in patients with diabetes and chronic kidney disease: insights from the Associazione Medici Diabetologi Annals initiative.
De Cosmo S; Viazzi F; Pacilli A; Giorda C; Ceriello A; Gentile S; Russo G; Rossi MC; Nicolucci A; Guida P; Di Bartolo P; Pontremoli R;
Nephrol Dial Transplant; 2015 Sep; 30(9):1526-33. PubMed ID: 25883195
[TBL] [Abstract][Full Text] [Related]
2. Glycaemic, blood pressure and lipid goal attainment and chronic kidney disease stage of type 2 diabetic patients treated in primary care practices.
Corcillo A; Pivin E; Lalubin F; Pitteloud N; Burnier M; Zanchi A
Swiss Med Wkly; 2017; 147():w14459. PubMed ID: 28695552
[TBL] [Abstract][Full Text] [Related]
3. [AMD Annals: a model of continuous monitoring and improvement of the quality of diabetes care].
Gruppo di studio ANNALI AMD
Epidemiol Prev; 2011; 35(1):18-26. PubMed ID: 21436491
[TBL] [Abstract][Full Text] [Related]
4. National survey: Evaluation of cardiovascular risk factors in Thai patients with type 2 diabetes and chronic kidney disease after the development of cardiovascular disease.
Changsirikulchai S; Sangthawan P; Janma J; Sripaiboonkij N; Rattanamongkolgul S; Thinkhamrop B
Nephrology (Carlton); 2018 Jan; 23(1):53-59. PubMed ID: 27608176
[TBL] [Abstract][Full Text] [Related]
5. Annual deterioration of renal function in hypertensive patients with and without diabetes.
Polonia J; Azevedo A; Monte M; Silva JA; Bertoquini S
Vasc Health Risk Manag; 2017; 13():231-237. PubMed ID: 28721063
[TBL] [Abstract][Full Text] [Related]
6. Improved home BP profile with dapagliflozin is associated with amelioration of albuminuria in Japanese patients with diabetic nephropathy: the Yokohama add-on inhibitory efficacy of dapagliflozin on albuminuria in Japanese patients with type 2 diabetes study (Y-AIDA study).
Kinguchi S; Wakui H; Ito Y; Kondo Y; Azushima K; Osada U; Yamakawa T; Iwamoto T; Yutoh J; Misumi T; Aoki K; Yasuda G; Yoshii T; Yamada T; Ono S; Shibasaki-Kurita T; Hosokawa S; Orime K; Hanaoka M; Sasaki H; Inazumi K; Yamada T; Kobayashi R; Ohki K; Haruhara K; Kobayashi Y; Yamanaka T; Terauchi Y; Tamura K
Cardiovasc Diabetol; 2019 Aug; 18(1):110. PubMed ID: 31455298
[TBL] [Abstract][Full Text] [Related]
7. [Comparison of clinical arterial pressure, home-arterial pressure measurement, and ambulatory arterial pressure monitoring in patients with type II diabetes mellitus and diabetic nephropathy].
Lou LM; Gimeno JA; Gómez Sánchez R; Labrador T; Beguer P; Lou MT; Boned B; Aguilar E
Nefrologia; 2002; 22(2):179-89. PubMed ID: 12085419
[TBL] [Abstract][Full Text] [Related]
8. Quality of care in patients with diabetic kidney disease in Asia: The Joint Asia Diabetes Evaluation (JADE) Registry.
Luk AO; Li X; Zhang Y; Guo X; Jia W; Li W; Weng J; Yang W; Chan WB; Ozaki R; Tsang CC; Mukhopadhyay M; Ojha AK; Hong EG; Yoon KH; Sobrepena L; Toledo RM; Duran M; Sheu W; Q Do T; Nguyen TK; Ma RC; Kong AP; Chow CC; Tong PC; So WY; Chan JC;
Diabet Med; 2016 Sep; 33(9):1230-9. PubMed ID: 26511783
[TBL] [Abstract][Full Text] [Related]
9. Health care delivery in type 2 diabetes. A survey in an Italian primary care practice.
Modesti A; Bartaloni R; Bellagamba F; Caglieri R; Cenori K; Ciampalini G; Costagli A; Galloni V; Del Papa C; Modesti L; Dell'Omo G; Pedrinelli R
Prim Care Diabetes; 2015 Feb; 9(1):9-14. PubMed ID: 24908631
[TBL] [Abstract][Full Text] [Related]
10. Predictors of chronic kidney disease in type 2 diabetes: A longitudinal study from the AMD Annals initiative.
De Cosmo S; Viazzi F; Pacilli A; Giorda C; Ceriello A; Gentile S; Russo G; Rossi MC; Nicolucci A; Guida P; Pontremoli R;
Medicine (Baltimore); 2016 Jul; 95(27):e4007. PubMed ID: 27399078
[TBL] [Abstract][Full Text] [Related]
11. Glycaemic, blood pressure and low-density lipoprotein-cholesterol control among patients with diabetes mellitus in a specialised clinic in Botswana: a cross-sectional study.
Mwita JC; Francis JM; Omech B; Botsile E; Oyewo A; Mokgwathi M; Molefe-Baikai OJ; Godman B; Tshikuka JG
BMJ Open; 2019 Jul; 9(7):e026807. PubMed ID: 31340960
[TBL] [Abstract][Full Text] [Related]
12. Utilization of statins and LDL-cholesterol target attainment in Turkish patients with type 2 diabetes - a nationwide cross-sectional study (TEMD dyslipidemia study).
Bayram F; Sonmez A; Haymana C; Sabuncu T; Dizdar OS; Gurkan E; Carlioglu AK; Agbaht K; Ozdemir D; Demirci I; Barcin C; Salman S; Tetiker T; Balci MK; Kebapci N; Ersoy C; Yumuk V; Toth PP; Satman I;
Lipids Health Dis; 2020 Nov; 19(1):237. PubMed ID: 33176832
[TBL] [Abstract][Full Text] [Related]
13. Concomitant reduction in low-density lipoprotein cholesterol and glycated hemoglobin with colesevelam hydrochloride in patients with type 2 diabetes: a pooled analysis.
Jialal I; Abby SL; Misir S; Nagendran S
Metab Syndr Relat Disord; 2009 Jun; 7(3):255-8. PubMed ID: 19344229
[TBL] [Abstract][Full Text] [Related]
14. Glycaemic, blood pressure and cholesterol control in 25 629 diabetics.
Pinchevsky Y; Butkow N; Chirwa T; Raal FJ
Cardiovasc J Afr; 2015; 26(4):188-92. PubMed ID: 26407221
[TBL] [Abstract][Full Text] [Related]
15. Management status and its predictive factors in patients with type 2 diabetes in China: A Nationwide Multicenter Study: A Nationwide Multicenter Study.
Liu L; Lou Q; Guo X; Yuan L; Shen L; Sun Z; Zhao F; Dai X; Huang J; Yang H; Mordes JP;
Diabetes Metab Res Rev; 2015 Nov; 31(8):811-6. PubMed ID: 26455830
[TBL] [Abstract][Full Text] [Related]
16. Glucagon-like peptide-1 receptor agonists reduced the low-density lipoprotein cholesterol in Japanese patients with type 2 diabetes mellitus treated with statins.
Hasegawa Y; Hori M; Nakagami T; Harada-Shiba M; Uchigata Y
J Clin Lipidol; 2018; 12(1):62-69.e1. PubMed ID: 29217412
[TBL] [Abstract][Full Text] [Related]
17. Seasonal Variations in the Achievement of Guideline Targets for HbA
Sakamoto M; Matsutani D; Minato S; Tsujimoto Y; Kayama Y; Takeda N; Ichikawa S; Horiuchi R; Utsunomiya K; Nishikawa M
Diabetes Care; 2019 May; 42(5):816-823. PubMed ID: 30739885
[TBL] [Abstract][Full Text] [Related]
18. Factors influencing optimal diabetes care and clinical outcomes in Thai patients with type 2 diabetes mellitus: a multilevel modelling analysis.
Surawit A; Pongkunakorn T; Manosan T; Mongkolsucharitkul P; Chamnan P; Suvarnabhumi K; Puangpet T; Suta S; Pumeiam S; Pinsawas B; Ophakas S; Pisitpornsuk S; Utchin C; Mayurasakorn K
BMJ Open; 2024 May; 14(5):e079415. PubMed ID: 38702083
[TBL] [Abstract][Full Text] [Related]
19. Relation between Blood Pressure Management and Renal Effects of Sodium-Glucose Cotransporter 2 Inhibitors in Diabetic Patients with Chronic Kidney Disease.
Kobayashi K; Toyoda M; Kaneyama N; Hatori N; Furuki T; Sakai H; Takihata M; Umezono T; Ito S; Suzuki D; Takeda H; Kanamori A; Degawa H; Yamamoto H; Machimura H; Mokubo A; Chin K; Obana M; Hishiki T; Aoyama K; Nakajima S; Umezawa S; Shimura H; Aoyama T; Miyakawa M
J Diabetes Res; 2019; 2019():9415313. PubMed ID: 31781668
[TBL] [Abstract][Full Text] [Related]
20. Fluctuation between fasting and 2-H postload glucose state is associated with chronic kidney disease in previously diagnosed type 2 diabetes patients with HbA1c ≥ 7%.
Wang C; Song J; Ma Z; Yang W; Li C; Zhang X; Hou X; Sun Y; Lin P; Liang K; Gong L; Wang M; Liu F; Li W; Yan F; Yang J; Wang L; Tian M; Liu J; Zhao R; Chen L
PLoS One; 2014; 9(7):e102941. PubMed ID: 25047354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
